The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
Open accessAbstract
BACKGROUND: Concerns have been raised over the safety of methylphenidate (MPH), with regard to adverse effects on growth and blood pressure. Our study investigates whether, and to what extent, methylphenidate use in boys with ADHD is associated with having low body mass index (BMI), having low height, and increased systolic and diastolic blood pressure. METHODS: Data used for this study stem from the German KiGGS dataset. Three different groups of boys aged 6-15 years were included in the analysis: ADHD patients who used MPH for less than 12 months; ADHD patients who used MPH for 12 months or more; and ADHD patients without current MPH treatment. Each of these three groups was compared to a non-ADHD control group regarding low weight (BMI ≤ 3rd percentile), low height (≤3rd percentile) and raised systolic and diastolic blood pressure. For growth outcomes, boys were categorized according to age (< 11 years/≥11 years, to account for pubertal maturation). Multivariable logistic regression was conducted to test for associations. RESULTS: 4244 boys were included in the study; MPH < 12 months: n = 65 (n = 36 < 11 years), MPH ≥ 12 months: n = 53 (n = 22 < 11 years), ADHD controls: n = 320 (n = 132 < 11 years), non-ADHD controls: n = 3806 (n = 2003 < 11 years). Pre-pubertal boys with MPH use less than 12 months and pubertal/postpubertal boys with MPH use of 12 months or greater were significantly more likely to have a BMI ≤ 3rd percentile compared to non-ADHD controls. Boys from the ADHD control group were significantly less likely to have a raised systolic blood pressure compared to non-ADHD controls. Beyond that, no significant between group differences were observed for any other growth and BP parameter. CONCLUSION: The analyses of the KiGGS dataset showed that MPH use in boys with ADHD is associated with low BMI. However, this effect was only observed in certain groups. Furthermore, our analysis was unable to confirm that MPH use is also associated with low height (≤3rd percentile) and changes in blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A study from Germany, however, specifically addressed whether stimulants predicted patients being very short (i.e., being less than or equal to the third percentile of the population). After comparing 3,806 boys not treated with methylphenidate with 118 treated boys, the results did not indicate that methylphenidate increased the probability of this adverse outcome (McCarthy et al., 2018).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as McCarthy et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · cited 1×
“The worldwide prevalence of ADHD among school-aged children and adolescents is around 5% [2, 3].”
BackgroundPolanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822 · cited 1×
“The worldwide prevalence of ADHD among school-aged children and adolescents is around 5% [2, 3].”
BackgroundAttention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationLurbe, E., Cifkova, R., Cruickshank, J. K., Dillon, M. J., Ferreira, I., Invitti, C., Kuznetsova, T., Laurent, S., Mancia, G., Morales-Olivas, F., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832f4f6b · Cited by 771 · cited 3×
“For the analysis of SBP and DBP, guidelines from the European Society of Hypertension [35] were used since these guidelines did not exclude overweight children unlike German reference data.”
BackgroundMethodInfluentialMedication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
Self-citationEvidence-based pharmacological treatment options for ADHD in children and adolescents
Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107940 · Cited by 293
Self-citationMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 163
Approach to Evaluating and Managing Adult Attention-Deficit/Hyperactivity Disorder in Primary Care
Huang, H. Y., Huang, H., Spottswood, M., & Ghaemi, S. N. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000248 · Cited by 27
Neurofeedback in ADHD: A qualitative study of strategy use in slow cortical potential training
Hasslinger, J., Souto, M. D., Folkesson, L., & Bölte, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233343 · Cited by 23
“Finally, long-term effects of pharmacological treatment are not well investigated, and concerns have been raised regarding the effectiveness of long-term symptom suppression and long-term side effects, in particular height suppression [22], lower body-mass-index [23] and cardiovascular functioning [24].”
Background
Metadata
- Authors
- McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., Häge, A., Hollis, C., Inglis, S., Kovshoff, H., Liddle, E., Mechler, K., Nagy, P., Rosenthal, E., Schlack, R., Sonuga-Barke, E., Zuddas, A., & Wong, I. C. K.
- Affiliations
- University College Cork (IE)
- Universitätsklinikum Erlangen (DE)
- Erasmus MC (NL)
- Heidelberg University (DE)
- Radboud University Medical Center (NL)
- University of Cagliari (IT)
- The University of Melbourne (AU)
- KU Leuven (BE)
- Inserm (FR)
- University of Nottingham (GB)
- University of Dundee (GB)
- University of Southampton (GB)
- Robert Koch Institute (DE)
- King's College London (GB)
- UCL School of Pharmacy (GB)
- Corresponding author
- McCarthy, Suzanne
- ORCID
- McCarthy, Suzanne
- Neubert, Antje
- Man, Kenneth K. C.
- Banaschewski, Tobias
- Buitelaar, Jan
- Carucci, Sara
- Coghill, David
- Danckaerts, Marina
- Falissard, Bruno
- Garas, Peter
- Häge, Alexander
- Hollis, Chris
- Kovshoff, Hanna
- Liddle, Elizabeth
- Mechler, Konstantin
- Schlack, Robert
- Sonuga-Barke, Edmund
- Zuddas, Alessandro
- Wong, Ian C. K.
- Venue
- BMC Psychiatry
- Published
- 2018-10-11
- Volume
- 18
- Issue
- 1
- Pages
- 327-327
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC6180569
- OpenAlex
- W2897137492
- Semantic Scholar
- ee0ddf309522a62628ce91909967bcd299237345
- Cited by
- 25
- References
- 50
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- heiDOK (Heidelberg University) (acceptedVersion, other-oa)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Lirias (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Cork Open Research Archive (University College Cork, Ireland) (submittedVersion, cc-by)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Robert-Koch-Institut (RKI) (cc-by)
- Funders
- FP7-HEALTH (260576)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, drug safety, growth, body mass index, height, blood pressure, children and adolescents, boys, pubertal development, chronic drug administration
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Blood Pressure, Body Height, Child, Cross-Sectional Studies, Drug Administration Schedule, Germany, Health Surveys, Humans, Male, Methylphenidate, Cohort Studies, Weight Loss, Body Mass Index, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). https://app.cochat.ai/papers/10.1186/s12888-018-1884-7
- The paper
- McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., Häge, A., Hollis, C., Inglis, S., Kovshoff, H., Liddle, E., Mechler, K., Nagy, P., Rosenthal, E., Schlack, R., . . . Wong, I. C. K. (2018). Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). BMC Psychiatry. https://doi.org/10.1186/s12888-018-1884-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.